Beraxol-Solopharm, 7.5 mg/ml 100 ml

Beraxol-SOLOfarm is an expectorant and mucolytic agent.

Pharmacological effect

Beraxol-SOLOpharm is an expectorant, mucolytic agent.

Special instructions

Beraxol-SOLOpharm should not be taken simultaneously with antitussive drugs that may inhibit the cough reflex.
Beraxol-SOLOpharm should be used with caution in patients with a weakened cough reflex or impaired mucociliary transport due to the possibility of sputum accumulation.

Active ingredient

Ambroxol

Composition

Composition of the drug per 1 ml:

Contraindications

Hypersensitivity to ambroxol or other components of the drug, pregnancy (first trimester), breastfeeding.

Side Effects

Gastrointestinal disorders: often – nausea, decreased sensitivity in the oral cavity and pharynx; uncommon – dyspepsia, pain in the upper abdomen, vomiting, diarrhea; rarely – heartburn, dryness of the mucous membrane of the mouth and pharynx, constipation.

Interaction

When used with antitussive drugs, it may be difficult to discharge sputum as a result of suppression of the cough reflex.

Overdose

Symptoms: heartburn, dyspepsia, diarrhea, nausea, vomiting, pain in the upper abdomen. There are reports of short-term anxiety.

Recommendations for use

The mucolytic effect of the drug occurs when taking large amounts of liquid. Therefore, drinking plenty of fluids is recommended during treatment.

Storage conditions

Store at a temperature not exceeding 25 °C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiration date!

Manufacturer

Grotex LLC, Russia